Topical beta-blocker therapy is a safe treatment for patients that meet a certain criteria
How Should Propranolol Be Initiated for Infantile Hemangiomas: Inpatient Versus Outpatient?
Current evidence supports that propranolol is safe to use for otherwise healthy infants with IH
An Unofficial First-Line Treatment: Propranolol gains widespread use for infantile hemangiomas
Since the first report in 2008 of the effectiveness of propranolol to treat infantile hemangiomas, its use has grown among physicians who treat these tumors, which arise in 5 to 10 percent of infants. Among these infants, approximately 10 percent will require treatment to correct functional impairment or prevent lasting cosmetic deformity caused by the hemangioma.
